CLINICAL_TRIALS
trial_result
· 2013-03-18
Clinical Trial Update: Zoledronate With Atorvastatin in Renal Cell Carcinoma [Phase 2]
Summary
Phase 2 trial assessing the combination of zoledronate and atorvastatin in renal cell carcinoma; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Kidney Cancer, Renal Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2013-03-18